featured
New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients With Second-Generation Drug-Eluting Stents
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: